Macrophage depletion inhibits HO formation. (A): Western blotting shows that BMP4 is expressed by thioglycollate-elicited peritoneal macrophages and that the transgene expression level is higher in inbred Nse-BMP4 mice than in Nse-BMP4/CD11b-DTR double transgenic mice. Each lane represents an individual mouse. β-Actin acts as the loading control. (B): BMP4 protein expression normalized to actin expression in WT, Nse-BMP4/CD11b-DTR, and inbred Nse-BMP4 mice. (C): Effect of macrophage depletion and transgene dosage. The percentages of mice that developed HO at different time points are depicted. Nse-BMP4 mice with clodronate (CLO, heavy green line) or without (phosphate buffered saline (PBS), heavy black line), Nse-BMP4/CD11b-DTR with DT (light blue line) or without (PBS, light black line) are presented. All other control groups, including WT mice with CLO or without (PBS), CD11b-DTR single transgenic mice with DT or without (PBS), never generate HO and are depicted. The thickness of the lines is proportional to the level of BMP4 transgene expression. Comparing the heavy green line with the heavy black line reveals the inhibitory effect of dlodronate treatment. Comparing the light blue line with the light black line reveals the inhibitory effect of DT treatment. Comparing the heavy black line with the light black line reveals the transgene dosage effect. The horizontal line at the bottom indicates the period of the injection following the injuries. Abbreviations: *, differs from WT by ANOVA at p < .05; **, differs from WT by ANOVA at p < .01; BMP, bone morphogenetic proteins; CLO, clodronate; DT, diphtheria toxin; DTR, DT receptor; HO, heterotopic ossification; Nse, neuron-specific enolase; WT, wild type.